Warner Chilcott

Error creating thumbnail:

Warner Chilcott was a pharmaceutical company that specialized in the development, manufacturing, and marketing of branded prescription pharmaceutical products. The company was known for its focus on women's healthcare, gastroenterology, dermatology, and urology.

History

Warner Chilcott was originally founded in 1968 as Galen Ltd. in Northern Ireland. The company underwent several transformations and rebrandings over the years. In 2000, it was renamed Warner Chilcott after acquiring the U.S.-based Warner Chilcott PLC. The company was publicly traded on the NASDAQ under the ticker symbol WCRX.

In 2013, Warner Chilcott was acquired by Actavis, a global pharmaceutical company, in a deal valued at approximately $8.5 billion. Following the acquisition, Warner Chilcott's operations were integrated into Actavis, which later became known as Allergan.

Products

Warner Chilcott's product portfolio included a range of branded prescription medications. Some of the notable products included:

• Loestrin - An oral contraceptive used for birth control.
• Asacol - A medication used to treat ulcerative colitis.
• Doryx - An antibiotic used to treat various bacterial infections.
• Enablex - A medication used to treat overactive bladder.

Focus Areas

Warner Chilcott focused on several key therapeutic areas:

• Women's Healthcare - The company developed and marketed products for contraception, hormone replacement therapy, and other women's health issues.
• Gastroenterology - Warner Chilcott offered treatments for gastrointestinal conditions such as ulcerative colitis and irritable bowel syndrome.
• Dermatology - The company provided medications for various skin conditions, including acne and psoriasis.
• Urology - Warner Chilcott developed treatments for urological conditions such as overactive bladder and benign prostatic hyperplasia.

Acquisition and Integration

In 2013, Warner Chilcott was acquired by Actavis, which significantly expanded Actavis' product portfolio and market presence. The acquisition allowed Actavis to strengthen its position in the specialty pharmaceuticals market, particularly in women's healthcare and gastroenterology.

Following the acquisition, Warner Chilcott's operations were fully integrated into Actavis. In 2015, Actavis acquired Allergan and adopted the Allergan name, further expanding its global footprint and product offerings.

Legacy

Warner Chilcott played a significant role in the pharmaceutical industry, particularly in the areas of women's healthcare and gastroenterology. The company's innovative products and strategic acquisitions helped shape the market and provided valuable treatments for patients worldwide.

See Also

• Actavis
• Allergan
• Pharmaceutical industry
• Women's healthcare
• Gastroenterology